(MENAFN- NewsBytes)
4 reasons why this year belongs to Rajkummar Rao
24 Nov 2017
Actor Rajkummar Rao was adjudged the best actor at the Asia Pacific Screen Awards held in Brisbane, for his performance in 'Newton', which also won the best screenplay award at the ceremony on Thursday.
This stellar actor has completely nailed every project he has undertaken this year.
Here's more about Rajkummar's victorious year so far!
When 'Newton' was chosen for Oscars
Oscar
Rajkummar Rao's 'Newton' is India's official entry in the Foreign Language Film category at the 2018 Oscars.
Newton revolves around a naive but idealistic election officer as he struggles to hold elections in a Naxal-infected village in Chattisgarh.
The film is written by Mayank Tewari and directed by Amit V Masurkar, who collected the best screenplay award in APSA.
Rajkummar's foray into digital world as 'Subhash Chandra Bose'
Web series
Call it a mere coincidence but one of Rajkummar's most anticipated projects went on floors this year: his first web-series. He essays the character of Subhash Chandra Bose, the series released on November 20.
'Bose: Dead or Alive' by AltBalaji has received tremendous response so far. Critics have gone far to say that this is the first Indian show to match International standards.
Three successful films back to back
Films
This year, the audience saw different facets of Rajkummar Rao as an actor as he had three different films to offer.
From 'Bareilly Ki Barfi', 'Behen Hogi Teri' and 'Shaadi Mein Zaroor Aana', Rajkummar was seen in a never before avatar in all the three films.
All the films were well-received by the audience and did a fairly good job at the box office.
MENAFN2411201701650000ID1096138843
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.